The predictive significance of CD20 expression in B-cell lymphomas

被引：0
|
作者：
Veronika Kloboves Prevodnik
Jaka Lavrenčak
Mateja Horvat
Barbara Jezeršek Novakovič
机构：
[1] Institute of Oncology,Department of Cytopathology
[2] Bayer d.o.o,Department of Medical Oncology
[3] Institute of Oncology,undefined
来源：
Diagnostic Pathology | / 6卷
关键词：
Chronic Lymphocytic Leukemia; CD20 Expression; Follicular Lymphoma; Mantle Cell Lymphoma; Hairy Cell Leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Prognostic Effect of CD20 Expression in Adult B-cell Acute Lymphoblastic Leukemia
    Esteban, Reiban-Espinoza
    Christianne, Bourlon
    Alvaro, Aguayo
    Roberta, Demichelis-Gomez
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (05): : 361 - 367
  • [32] Ublituximab for the treatment of CD20 positive B-cell malignancies
    Babiker, Hani M.
    Glode, Ashley E.
    Cooke, Laurence S.
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 407 - 412
  • [33] CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies
    Bobrowicz, Malgorzata
    Kusowska, Aleksandra
    Krawczyk, Marta
    Zhylko, Andriy
    Forcados, Christopher
    Slusarczyk, Aleksander
    Barankiewicz, Joanna
    Domagala, Joanna
    Kubacz, Matylda
    Smida, Michal
    Dostalova, Lenka
    Marhelava, Katsiaryna
    Fidyt, Klaudyna
    Pepek, Monika
    Baranowska, Iwona
    Szumera-Cieckiewicz, Anna
    Inderberg, Else Marit
    Walchli, Sebastien
    Granica, Monika
    Graczyk-Jarzynka, Agnieszka
    Majchrzak, Martyna
    Poreba, Marcin
    Gehlert, Carina Lynn
    Peipp, Matthias
    Firczuk, Malgorzata
    Prochorec-Sobieszek, Monika
    Winiarska, Magdalena
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [34] FLUORESCENT INTENSITY (FI) EXPRESSION AND DISTRIBUTION OF CD20 IN B-CELL LYMPHOCYTIC LYMPHOMAS - CORRELATION WITH MORPHOLOGIC, PHENOTYPIC AND MOLECULAR-FEATURES
    MASIH, AS
    SCOTT, MP
    GASKIN, GM
    BRAYLAN, RC
    LABORATORY INVESTIGATION, 1994, 70 (01) : A115 - A115
  • [35] "Double-Hit" Mature B-Cell Lymphomas Show a Common Immunophenotype by Flow Cytometry That Includes Decreased CD20 Expression
    Wu, David
    Wood, Brent L.
    Dorer, Russell
    Fromm, Jonathan R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (02) : 258 - 265
  • [36] Lw-213 Synergizes with Rituximab to Inhibit Diffuse Large B-Cell Lymphomas By Upregulating CD20
    Li, Yuchen
    Li, Hui
    Hui, Hui
    Xu, Jingyan
    BLOOD, 2021, 138
  • [37] Prognostic Significance of CD20 Expression in Children with Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia
    Wang, Yu
    Xue, Yu-juan
    Jia, Yue-ping
    Zuo, Ying-xi
    Lu, Ai-dong
    Zhang, Le-ping
    ACTA HAEMATOLOGICA, 2023, 146 (05) : 349 - 357
  • [38] Comparative biodistributions of pretargeted radioimmunoconjugates targeting CD20, CD22, and DR molecules on human B-cell lymphomas
    Pantelias, Anastasia
    Pagel, John M.
    Hedin, Nathan
    Saganic, Laura
    Wilbur, Shani
    Hamlin, Donald K.
    Wilbur, D. Scott
    Lin, Yukang
    Stone, Diane
    Axworthy, Don
    Gopal, Ajay K.
    Press, Oliver W.
    BLOOD, 2007, 109 (11) : 4980 - 4987
  • [39] Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in B-cell malignancies.
    Treon, SP
    Mitsiades, CS
    Mitsiades, NS
    Young, G
    Doss, DS
    Schlossman, RL
    Anderson, KC
    BLOOD, 2000, 96 (11) : 99A - 99A
  • [40] Evaluation of CYCLON as a predictive biomarker of anti CD20 response in diffuse large B-Cell lymphoma
    Bouroumeau, A.
    Bussot, L.
    Bonnefoix, T.
    Callanan, M.
    Gressin, R.
    Emadali, A.
    Sartelet, H.
    VIRCHOWS ARCHIV, 2019, 475 : S338 - S338
12345